Cargando…
Comparison of Iodide-125 and Ruthenium-106 Brachytherapy in the Treatment of Choroidal Melanomas
BACKGROUND: To compare iodine-125 ((125)I) with ruthenium-106 ((106)Ru) episcleral plaque radiation therapy in terms of the effectiveness and non-inferiority for choroidal melanoma treatment. OBJECTIVE: To report the non-inferiority of new made iodine-125 ((125)I) compared with ruthenium-106 ((106)R...
Autores principales: | Ghassemi, Fariba, Sheibani, Shahab, Arjmand, Mojtaba, Poorbaygi, Hosein, Kouhestani, Emad, Sabour, Siamak, Samiei, Farhad, Beiki-Ardakani, Akbar, Jabarvand, Mahmood, Sadeghi Tari, Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7007774/ https://www.ncbi.nlm.nih.gov/pubmed/32099319 http://dx.doi.org/10.2147/OPTH.S235265 |
Ejemplares similares
-
Evaluation of dosimetric functions for a new (169)Yb HDR Brachytherapy Source
por: Safaeipour, Elham, et al.
Publicado: (2021) -
Dosimetric Investigation of Six Ru-106 Eye Plaques by EBT3 Radiochromic Films and Monte Carlo Simulation
por: Arjmand, Mojtaba, et al.
Publicado: (2023) -
Brachytherapy of Uveal Melanomas with Ruthenium-106 Plaques
por: Belaïd, Asma, et al.
Publicado: (2016) -
Long-Term Outcomes in Uveal Melanoma After Ruthenium-106 Brachytherapy
por: Cennamo, Gilda, et al.
Publicado: (2022) -
(106)Ruthenium eye plaque brachytherapy in the management of medium sized uveal melanoma
por: Jiang, Ping, et al.
Publicado: (2020)